Amersham Biosciences, Helix

Nov 07, 2003

Premium

Amersham Biosciences has released a group of Biotrak ELISA substrates for biomarkers involved in neurodegenerative research. The markers include: beta amyloid 1-20, beta amyloid 1-42, and alpha synuclein. The assays have been validated to measure disease samples including brain tissue, serum, plasma, and cerebrospinal fluid.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Breaking News

The Scan

All About the Proteins

The New York Times Magazine writes that proteomics might be better poised than genomics to say when someone is falling ill.

Lab Space and a Dream

Bloomberg profiles IndieBio, a startup incubator for the life sciences.

"Must Stop"

In an editorial, Nature calls for the end to the exploitation of foreign postdocs.

This Week in Nucleic Acids Research

In Nucleic Acids Research this week: collection of epigenome-wide association study data, updated BloodSpot database, and more.

Featured White Papers

xMAP Cookbook: A collection of methods and protocols for developing multiplex assays with xMAP Technology

Stroma Liquid Biopsy - Biomarkers of the Dysregulation of the Serum Proteome in Cancer

Cleanascite Lipid Removal & Clarification Reference Applications

Albumin Removal Reference Applications

Dec

03

Featured Webinar

Application of a Novel ISH Approach to Elucidate Splice Variants in Schizophrenia

This webinar will demonstrate how a research team at the National Institutes of Health evaluated a novel in situ hybridization approach and applied it to study splice variants related to schizophrenia.

Main menu